What You Should Know:
- Apstar Pharma acquires the assets of respiratory health company Cohero Health to expands its digital portfolio with a focus on respiratory disease management.
- Cohero Health develops digital tools and technologies to improve respiratory care, reduce avoidable costs, and optimize medication utilization.
AptarGroup, Inc., a global leader in consumer dispensing, active packaging, drug delivery solutions, and services, announces that it has acquired all operating
Read More
Smart Inhaler
Syqe Medical, TerrAscend to Distribute Medical Cannabis Inhaler to Canadian Market
- Syqe Medical, Ltd. and TerrAscend Corp. announced an exclusive distribution agreement to bring Syqe’s flagship product, the SyqeTM Inhaler, to the Canadian market.
- TerrAscend will utilize their platform to both provide high-quality guidance to patients on use of the Syqe device and educate the medical community on the benefits of medical cannabis and the Syqe treatment.
- For the first time ever, the amount of THC in the bloodstream can be accurately controlled in a consistent,
Read More
Syqe Medical Releases Pharmaceutical-Grade Medical Marijuana Inhaler
Syqe Medical, an Israeli pharma-tech company, recently launched its newest administering device for cannabis in the form of a non-combustion inhaler.
The Syqe Inhaler™ is the company’s flagship product that utilizes innovative technology to administer proper doses of cannabis for medical marijuana patients in Israel. Syqe’s breakthrough drug delivery technology introduces complex respiration technique automation, electronic selective dosing, remote clinical monitoring and dose
Read More
Cleveland Clinic Study: Propeller Health’s Smart Inhalers Reduces Hospitalizations, ER Visits for COPD Patients
Cleveland Clinic today released research that uses Propeller Health’s smart inhaler platform to show that digital medicines significantly reduced hospital visits for COPD patients. COPD is a term applied to a family of diseases that includes emphysema, chronic bronchitis, and emphysema due to alpha-1 antitrypsin deficiency. The research findings published in The Journal of Telemedicine and Telecare marks the first-ever research to assess the impact of a digital medicine on healthcare utilization
Read More
Propeller Health: 84% of People with Asthma May Be Using Their Inhaler Incorrectly
The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology. Traditionally, asthma medicines require that patients take two "puffs" of their inhaler to receive the prescribed dose. Recommended Asthma Inhaler GuidelinesAsthma guidelines and patient instructions for inhaled medications recommend that
Read More
Study: Propeller’s Smart Inhaler for Asthma Management Improves Patient Satisfaction
A new peer-reviewed study published in the Journal of Medical Internet Research mHealth and uHealth demonstrated high levels of patient satisfaction with Propeller Health's smart inhaler for asthma management. Although digital health tools are increasingly recognized as effective in improving clinical outcomes such as asthma control and medication adherence, few studies have assessed patient experiences and perception of value. "I was never sure how often I used my rescue inhaler. When my doctor
Read More
Resolve Digital Health Lands $5M to Launch First Smart Inhaler for Medical Cannabis
Resolve Digital Health, a Toronto, Canada-based digital health startup has raised $5 million in Series A funding led by Aphria Inc to launch the world's first smart inhaler for medical cannabis to help patients suffering from cancer, arthritis, migraine headaches, chronic pain and other diseases. The latest round marks the next phase in the company's development with the upcoming California launch of their debut medical device system, Breeze this spring at exclusive dispensary partners in
Read More
Propeller Health Lands FDA 510(k) Clearance to Market Sensor for the Ellipta Inhaler
Propeller Health, a Madison, Wisconsin-based provider of digital solutions for respiratory medicine has received FDA 510(k) clearance to market its digital sensor for use with GSK’s Ellipta® patented, dry powder inhaler. The custom sensor designed exclusively for the Ellipta inhaler was cleared as part of a R&D collaboration between Propeller and GSK announced in late 2015.For the R&D collaboration, the Propeller sensor automatically collected and recorded data on the Ellipta inhaler's
Read More
Teva To Acquire Gecko Health Innovations for its Smart Inhaler
Israeli generic drugmaker Teva Pharmaceuticals Industries Ltd. has reached an agreement to acquire mobile health technology company Gecko Health Innovations, Inc. The acquisition will help strengthen Teva's respiratory capabilities and help reinforce its leadership position in respiratory care. Financial terms of the deal were not disclosed.
CareTRx (formerly GeckoCap) is a cloud-based solution designed to simplify chronic respiratory disease management, connecting patients and caregivers
Read More
